# Epigenetic remodeling during early embryonic development

**Authors:** Xiaoyu Wan, Shibin Zhang, Jingyu Li, Deying Kong, Mo Chen

PMC · DOI: 10.3389/fcell.2026.1750381 · Frontiers in Cell and Developmental Biology · 2026-02-17

## TL;DR

This review explores how epigenetic changes shape early embryonic development in mice and humans, focusing on DNA and histone modifications.

## Contribution

The paper provides a comprehensive synthesis of recent advances in epigenetic reprogramming during early embryogenesis.

## Key findings

- Epigenetic reprogramming involves dynamic changes in DNA methylation and chromatin architecture.
- Histone modifications like methylation and acetylation play key roles in regulating gene expression during development.
- Metabolism-linked modifications such as crotonylation and lactylation are emerging as important regulators of transcription.

## Abstract

In mammals, the fusion of sperm and oocyte gives rise to a totipotent zygote, which undergoes a series of cleavage divisions and differentiation events. During this process, the embryo transitions from totipotency to pluripotency, accompanied by extensive epigenetic reprogramming. With continuous innovation of low-input multi-omics technology and other methods, the relationship between epigenetic remodeling and embryonic development has been gradually revealed. This review synthesizes recent advances in our understanding of the dynamics of epigenetic reprogramming during early embryogenesis in mice and humans. It covers the remodeling of DNA methylation, histone modifications, chromatin accessibility, and three-dimensional chromatin architecture, with a particular focus on the dynamic features of histone modifications. The patterns of common histone modifications such as methylation, acetylation, and ubiquitination are elaborated. Furthermore, the review outlines both the emerging roles of metabolism-associated modifications such as crotonylation and lactylation in genomic targeting and transcriptional regulation, and the dynamic patterns of histone variant incorporation.

## Linked entities

- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** KDM6B (lysine demethylase 6B) [NCBI Gene 23135] {aka JMJD3, NEDCFSA, NEDSST}, TET3 (tet methylcytosine dioxygenase 3) [NCBI Gene 200424] {aka BEFAHRS, hCG_40738}, Prc1 (protein regulator of cytokinesis 1) [NCBI Gene 233406] {aka D7Ertd348e}, Kat2b (K(lysine) acetyltransferase 2B) [NCBI Gene 18519] {aka A930006P13Rik, Pcaf, p/CAF}, PRC1 (protein regulator of cytokinesis 1) [NCBI Gene 9055] {aka ASE1, MAP65}, OTX2 (orthodenticle homeobox 2) [NCBI Gene 5015] {aka CPHD6, MCOPS5}, Kdm5b (lysine demethylase 5B) [NCBI Gene 75605] {aka 2010009J12Rik, 2210016I17Rik, D1Ertd202e, Jarid1b, PLU-1, PUT1}, Cbx5 (chromobox 5) [NCBI Gene 12419] {aka 2610029O15Rik, HP1, Hp1a, Hp1alpha}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, Kmt2b (lysine (K)-specific methyltransferase 2B) [NCBI Gene 75410] {aka 2610014H22Rik, Mll2, Wbp7, mKIAA0304}, NANOG (Nanog homeobox) [NCBI Gene 79923], TFAP2C (transcription factor AP-2 gamma) [NCBI Gene 7022] {aka AP2-GAMMA, ERF1, TFAP2G, hAP-2g}, Kdm4a (lysine (K)-specific demethylase 4A) [NCBI Gene 230674] {aka D4Ertd222e, JHDM3A, Jmjd2, Jmjd2a, mKIAA0677}, KAT8 (lysine acetyltransferase 8) [NCBI Gene 84148] {aka LIGOWS, MOF, MYST1, ZC2HC8, hMOF}, Crebbp (CREB binding protein) [NCBI Gene 12914] {aka CBP, CBP/p300, KAT3A, p300/CBP}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, EED (embryonic ectoderm development) [NCBI Gene 8726] {aka COGIS, HEED, WAIT1}, DNMT3L (DNA methyltransferase 3 like) [NCBI Gene 29947], Kmt2c (lysine (K)-specific methyltransferase 2C) [NCBI Gene 231051] {aka E330008K23Rik, HALR, Mll3}, USP7 (ubiquitin specific peptidase 7) [NCBI Gene 7874] {aka C16DELp13.2, DEL16P13.2, HAFOUS, HAUSP, TEF1}, DNMT1 (DNA methyltransferase 1) [NCBI Gene 1786] {aka ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT}, CTCF (CCCTC-binding factor) [NCBI Gene 10664] {aka CFAP108, FAP108, MRD21}, TGFBR1 (transforming growth factor beta receptor 1) [NCBI Gene 7046] {aka AAT5, ACVRLK4, ALK-5, ALK5, ESS1, LDS1}, Dnmt3b (DNA methyltransferase 3B) [NCBI Gene 13436] {aka MmuIIIB}, Setd2 (SET domain containing 2) [NCBI Gene 235626] {aka 4921524K10Rik, KMT3A}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, Dux (double homeobox) [NCBI Gene 664783] {aka AW822073, Dux4, Duxbl, EG664783}, Fam167b (family with sequence similarity 167, member B) [NCBI Gene 230766] {aka SEC}, CDX2 (caudal type homeobox 2) [NCBI Gene 1045] {aka CDX-3, CDX2/AS, CDX3}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, Ctcf (CCCTC-binding factor) [NCBI Gene 13018], ZNF143 (zinc finger protein 143) [NCBI Gene 7702] {aka SBF, STAF, pHZ-1}, POU5F1 (POU class 5 homeobox 1) [NCBI Gene 5460] {aka OCT3, OCT4, OCT4Borf1, OTF-3, OTF3, OTF4}, Dnmt3a (DNA methyltransferase 3A) [NCBI Gene 13435] {aka MmuIIIA}, UHRF1 (ubiquitin like with PHD and ring finger domains 1) [NCBI Gene 29128] {aka ICBP90, Np95, RNF106, TDRD22, hNP95, hUHRF1}, USP16 (ubiquitin specific peptidase 16) [NCBI Gene 10600] {aka UBP-M, UBPM}, Setdb1 (SET domain, bifurcated 1) [NCBI Gene 84505] {aka ESET, KMT1E, mKIAA0067}, H2az1 (H2A.Z variant histone 1) [NCBI Gene 51788] {aka H2A.Z, H2A.Z1, H2a.z-1, H2afz}, Dnmt3l (DNA methyltransferase 3-like) [NCBI Gene 54427] {aka D6Ertd14e, ecat7}, Kat2a (K(lysine) acetyltransferase 2A) [NCBI Gene 14534] {aka 1110051E14Rik, Gcn5, Gcn5l2, mmGCN5}, DNMT3B (DNA methyltransferase 3 beta) [NCBI Gene 1789] {aka FSHD4, ICF, ICF1, M.HsaIIIB}, HCFC1 (host cell factor C1) [NCBI Gene 3054] {aka CFF, HCF, HCF-1, HCF1, HFC1, MAHCX}, H33 (histocompatibility 33) [NCBI Gene 109836] {aka H-33}, Kmt2d (lysine (K)-specific methyltransferase 2D) [NCBI Gene 381022] {aka ALR, C430014K11Rik, KMT2B, Mll2, Mll4, bapa}, DNMT3A (DNA methyltransferase 3 alpha) [NCBI Gene 1788] {aka DNMT3A2, HESJAS, M.HsaIIIA, TBRS}
- **Diseases:** embryonic lethality (MESH:D020964), ZGA (MESH:D042822), TS (MESH:D005879), embryonic arrest (MESH:D018236), SCNT (MESH:D013001), arrest (MESH:D006323), developmental defects (MESH:D000094602), hypoxic (MESH:D002534)
- **Chemicals:** H3K27ac (-), 5-carboxylcytosine (MESH:C560974), lactate (MESH:D019344), 5-methylcytosine (MESH:D044503)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** ESCs — Mus musculus (Mouse), Embryonic stem cell (CVCL_9108), hESCs — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_C464)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953372/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953372/full.md

## References

177 references — full list in the complete paper: https://tomesphere.com/paper/PMC12953372/full.md

---
Source: https://tomesphere.com/paper/PMC12953372